Evidence map›Paper›PMID 31142747›Full record

ArticleNature communications2019

Ep400 deficiency in Schwann cells causes persistent expression of early developmental regulators and peripheral neuropathy.

Franziska Fröb, Elisabeth Sock, Ernst R Tamm, Anna-Lena Saur, Simone Hillgärtner, Trevor J Williams, Toshihiro Fujii, Rikiro Fukunaga, Michael Wegner

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Schwann Cell Development and Myelination.Cold Spring Harbor perspectives in biology · 2024
    Review
  6. Article
  7. Article
  8. Chromatin Modifier EP400 Regulates Oocyte Quality and Zygotic Genome Activation in Mice.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Franziska FröbInstitut für Biochemie, Emil-Fischer-Zentrum, Friedrich-Alexander-Universität Erlangen-Nürnberg, Fahrstrasse 17, 91054, Erlangen, Germany.ORCID http://orcid.org/0000-0002-6404-8631
Elisabeth SockInstitut für Biochemie, Emil-Fischer-Zentrum, Friedrich-Alexander-Universität Erlangen-Nürnberg, Fahrstrasse 17, 91054, Erlangen, Germany.ORCID http://orcid.org/0000-0001-9925-3136
Ernst R TammInstitut für Humananatomie und Embryologie, Universität Regensburg, Universitätsstrasse 31, 93053, Regensburg, Germany.
Anna-Lena SaurInstitut für Biochemie, Emil-Fischer-Zentrum, Friedrich-Alexander-Universität Erlangen-Nürnberg, Fahrstrasse 17, 91054, Erlangen, Germany.
Simone HillgärtnerInstitut für Biochemie, Emil-Fischer-Zentrum, Friedrich-Alexander-Universität Erlangen-Nürnberg, Fahrstrasse 17, 91054, Erlangen, Germany.
Trevor J WilliamsDepartments of Craniofacial Biology and Cell and Developmental Biology, UC Denver, Anschutz Medical Campus, 12801 East 17th Avenue, Aurora, CO, 80045, USA.
Toshihiro FujiiDepartment of Biochemistry, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan.
Rikiro FukunagaDepartment of Biochemistry, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan.ORCID http://orcid.org/0000-0001-8972-8863
Michael WegnerInstitut für Biochemie, Emil-Fischer-Zentrum, Friedrich-Alexander-Universität Erlangen-Nürnberg, Fahrstrasse 17, 91054, Erlangen, Germany. michael.wegner@fau.de.ORCID http://orcid.org/0000-0002-4586-3294
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEOsaka University of Pharmaceutical Sciences · JPUniversity of Colorado Anschutz Medical Campus · USUniversity of Regensburg · DE

Funding

THE ROLE OF AP-2 IN CRANIOFACIAL DEVELOPMENTR01DE012728 · NIDCR · YALE UNIVERSITY · PI WILLIAMS, TREVOR J · 1998 to 2013
$5.5M
Deutsche Forschungsgemeinschaft (German Research Foundation) GRK2162Deutsche Forschungsgemeinschaft (German Research Foundation) We1326/14NIDCR NIH HHS R01 DE012728U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (NIDCR) DE12728
6 · The paper itself

Abstract

Schwann cells ensure efficient nerve impulse conduction in the peripheral nervous system. Their development is accompanied by defined chromatin changes, including variant histone deposition and redistribution. To study the importance of variant histones for Schwann cell development, we altered their genomic distribution by conditionally deleting Ep400, the central subunit of the Tip60/Ep400 complex. Ep400 absence causes peripheral neuropathy in mice, characterized by terminal differentiation defects in myelinating and non-myelinating Schwann cells and immune cell activation. Variant histone H2A.Z is differently distributed throughout the genome and remains at promoters of Tfap2a, Pax3 and other transcriptional regulator genes with transient function at earlier developmental stages. Tfap2a deletion in Ep400-deficient Schwann cells causes a partial rescue arguing that continued expression of early regulators mediates the phenotypic defects. Our results show that proper genomic distribution of variant histones is essential for Schwann cell differentiation, and assign importance to Ep400-containing chromatin remodelers in the process.

Indexed as

AnimalsChromatin Assembly and DisassemblyDNA-Binding ProteinsDNA HelicasesGene Expression Regulation, DevelopmentalHistonesMiceMice, TransgenicPAX3 Transcription FactorPeripheral Nervous System DiseasesPromoter Regions, GeneticSchwann CellsSciatic NerveTranscription Factor AP-2Transcription FactorsDNA-Binding ProteinsDNA HelicasesEp400 protein, mouseHistonesPax3 protein, mousePAX3 Transcription FactorTfap2a protein, mouseTranscription Factor AP-2Transcription Factors

Identifiers

PMID31142747
PMCPMC6541636
OpenAlexW2947380657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.